Aytu BioScience
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $16,106 | $12,411 | $15,165 | $13,888 |
Gross Profit | 11,696 | 6,838 | 9,098 | 9,186 |
EBITDA | 1,422 | -4,051 | -9,139 | 3,284 |
EBIT | 301 | -5,172 | -10,024 | 2,481 |
Net Income | -15 | -5,618 | -10,584 | 1,965 |
Net Change In Cash | 16,106 | 12,411 | 15,165 | 13,888 |
Free Cash Flow | 4,394 | -4,182 | 3,658 | -618 |
Cash | 26,308 | 26,715 | 30,025 | 32,630 |
Basic Shares | 12,318 | 10,511 | 10,036 | 19,476 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $57,570 | $66,382 | $65,183 | $107,399 |
Gross Profit | 36,818 | 45,831 | 49,054 | 66,632 |
EBITDA | -4,384 | -4,665 | 1,406 | -3,273 |
EBIT | -8,314 | -10,042 | -5,319 | -12,088 |
Net Income | -14,252 | -13,562 | -15,844 | -17,051 |
Net Change In Cash | 57,570 | 66,382 | 65,183 | 107,399 |
Free Cash Flow | 3,252 | -5,165 | -1,717 | -5,129 |
Cash | 26,308 | 30,952 | 20,006 | 22,985 |
Basic Shares | 12,318 | 6,279 | 5,537 | 3,339 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.05 |
2026-03-31 | -$0.41 |
2025-12-31 | -$0.23 |
2025-09-30 | -$0.09 |